Diabetes, Vol 49, Issue 7 1131-1136, Copyright © 2000 by American Diabetes Association

ARTICLES

K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin

M Kullin, Z Li, JB Hansen, E Bjork, S Sandler and FA Karlsson
Department of Medical Sciences, Uppsala University, Sweden.

We examined the influence of two K(ATP) channel openers, diazoxide and an analog (NNC 55-0118), on experimental beta-cell damage induced by streptozotocin (STZ; 0.5 mmol/l). Rat pancreatic islets were exposed to diazoxide or NNC 55-0118 for 30 min and were further incubated for 30 min after the addition of STZ. The islets were then washed and cultured for 24 h. Islets exposed to STZ alone showed extensive morphological damage, reduced glucose oxidation, low insulin content, and severely impaired glucose-stimulated insulin secretion and proinsulin biosynthesis. Islets treated with STZ in the presence of the channel openers (0.03-0.30 mmol/l) showed dose-dependent preservation of the morphology and improved glucose oxidation rates, insulin content, and secretion. NNC 55-0118 was capable of fully counteracting the STZ impairment, whereas diazoxide had a less protective effect. NNC 55-0118 did not counteract STZ-induced depression of islet NAD levels when examined 2 h after STZ exposure, which suggests that the mechanism of action by NNC 55-0118 is not through an inhibition of poly(ADP-ribose) polymerase. The results illustrate that K(ATP) channel openers can protect insulin-producing cells against toxic damage, an effect that may be of use in subjects with ongoing insulitis.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. E. Rabaglia, M. P. Gray-Keller, B. L. Frey, M. R. Shortreed, L. M. Smith, and A. D. Attie {alpha}-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E218 - E224. [Abstract] [Full Text] [PDF]

				L Zhao, Z Li, M Kullin, L A H Borg, and F A Karlsson Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli J. Endocrinol., May 1, 2005; 185(2): 291 - 299. [Abstract] [Full Text] [PDF]

				E. Ortqvist, E. Bjork, M. Wallensteen, J. Ludvigsson, J. Aman, C. Johansson, G. Forsander, F. Lindgren, L. Berglund, M. Bengtsson, et al. Temporary Preservation of {beta}-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes Diabetes Care, September 1, 2004; 27(9): 2191 - 2197. [Abstract] [Full Text] [PDF]

				K. Skak, C. F. Gotfredsen, D. Lundsgaard, J. B. Hansen, J. Sturis, and H. Markholst Improved {beta}-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a {beta}-Cell-Selective KATP Channel Opener Diabetes, April 1, 2004; 53(4): 1089 - 1095. [Abstract] [Full Text] [PDF]

				R. D. Carr, C. L. Brand, T. B. Bodvarsdottir, J. B. Hansen, and J. Sturis NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat Diabetes, October 1, 2003; 52(10): 2513 - 2518. [Abstract] [Full Text] [PDF]

				L. Jansson, M. Kullin, F. A. Karlsson, B. Bodin, J. B. Hansen, and S. Sandler KATP Channels and Pancreatic Islet Blood Flow in Anesthetized Rats: Increased Blood Flow Induced by Potassium Channel Openers Diabetes, August 1, 2003; 52(8): 2043 - 2048. [Abstract] [Full Text] [PDF]